Pei Xu
Vermögen: 41 $ am 30.06.2026
Vermögen: 41 $ am 30.06.2026
Pei Xu is the founder of Zhongchao, Inc., founded in 2019, serving as Chief Financial Officer, Secretary & Director.
Current jobs include Independent Director at Estrella Immunopharma, Inc., and Chief Financial Officer at Zhongchao Medical Technology (Shanghai) Corp.
since 2016.
Former job includes Financial Director at Otsuka (China) Investment Co., Ltd. from 2008 to 2013.
Education includes an undergraduate degree from Jiangxi University of Finance & Economics.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.04.2026 | 39 ( 0% ) | 41 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ZHONGCHAO INC. | Gründer | 16.04.2019 |
| ESTRELLA IMMUNOPHARMA, INC. | Direktor/Vorstandsmitglied | - |
Zhongchao Medical Technology (Shanghai) Corp. | Finanzdirektor/CFO | 01.09.2013 |
| Unternehmen | Position | Ende |
|---|---|---|
Otsuka (China) Investment Co., Ltd. | Finanzdirektor/CFO | 01.08.2013 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Otsuka (China) Investment Co., Ltd. | |
Jiangxi University of Finance & Economics
Jiangxi University of Finance & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zhongchao, Inc.
Zhongchao, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as holding company whose subsidiaries provides healthcare information, education and training services to healthcare professionals | Commercial Services |
Zhongchao Medical Technology (Shanghai) Corp. | |
Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc. BiotechnologyHealth Technology Operates as a preclinical-stage biopharmaceutical company focusing on cancer therapeutics to address treatment of blood cancers and solid tumors | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen